| Identification | Back Directory | [Name]
H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH | [CAS]
197151-46-5 | [Synonyms]
CATESTATIN (HUMAN)
Catestatin (human) trifluoroacetate salt
H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH
Catestatin (human) trifluoroacetate salt H-Ser-Ser-Met-Lys-Leu-Ser-Phe-Arg-Ala-Arg-Ala-Tyr-Gly-Phe-Arg-Gly-Pro-Gly-Pro-Gln-Leu-OH trifluoroacetate salt
L-Leucine, L-seryl-L-seryl-L-methionyl-L-lysyl-L-leucyl-L-seryl-L-phenylalanyl-L-arginyl-L-alanyl-L-arginyl-L-alanyl-L-tyrosylglycyl-L-phenylalanyl-L-arginylglycyl-L-prolylglycyl-L-prolyl-L-glutaminyl- | [Molecular Formula]
C104H164N32O27S | [MDL Number]
MFCD16879062 | [MOL File]
197151-46-5.mol | [Molecular Weight]
2326.68 |
| Hazard Information | Back Directory | [Uses]
Catestatin human, a catecholamine release-inhibitory peptide, is a pleiotropic peptide involved in cardiovascular protection with its antihypertensive and angiogenic effects. Catestatin human can be used in the study of inflammatory diseases [1]. | [References]
[1] Daniel T O'Connor, et al. Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension. J Hypertens. 2002 Jul;20(7):1335-45. DOI:10.1097/00004872-200207000-00020 |
|
| Company Name: |
BOC Sciences
|
| Tel: |
1-631-485-4226; 16314854226 |
| Website: |
https://www.bocsci.com |
|